Ionis Pharmaceuticals Inc (NAS:IONS)
$ 38.42 -0.38 (-0.98%) Market Cap: 5.61 Bil Enterprise Value: 4.90 Bil PE Ratio: 0 PB Ratio: 18.93 GF Score: 70/100

Ionis Pharmaceuticals Inc at Stifel CNS Days (Virtual) Transcript

Mar 29, 2023 / 02:00PM GMT
Release Date Price: $35.48 (+3.47%)
Paul Andrew Matteis
Stifel, Nicolaus & Company, Incorporated, Research Division - Co-Head of the Biotech Team, MD & Senior Analyst

Great. Thanks very much, everybody. It's a very topical time to have a CNS-focused discussion with Ionis, given some tau data this morning and tofersen AdCom, and maybe I can kick it off. We've got Eric and Holly here, who are very in depth on all this stuff and you both have been at Ionis for a while.

Questions & Answers

Paul Andrew Matteis
Stifel, Nicolaus & Company, Incorporated, Research Division - Co-Head of the Biotech Team, MD & Senior Analyst

As we sort of sit here today, I know you have a lot of different programs, what are the 1 to 2 things that are getting you most excited within your CNS pipeline today? Yes, maybe we can start with that.

Eric E. Swayze
Ionis Pharmaceuticals, Inc. - EVP of Research

Yes, sure. Well, thanks for having us on, Paul. We really appreciate it. We love to talk about neurology as you well know. So I guess the things that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot